We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWL:NASDAQNewell Brands Inc. Analysis

Data as of 2026-06-09 - not real-time

$4.38

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its longer‑term moving averages, with the short‑term average under the medium‑term average, reinforcing a bearish technical stance. Momentum indicators show the relative strength index in the upper half of its scale, hinting at lingering buying pressure but not yet overbought. The MACD histogram has turned positive while the line remains below the signal, suggesting a tentative bullish shift that lacks confirmation. Volume has been trending upward, adding weight to recent price moves. Recent price action sits near the lower end of the recent range, with resistance near the upper end, framing a narrow trading corridor. The beta is well above one and month‑to‑month volatility is extreme, indicating the stock is highly sensitive to market swings.
Core sales have slipped year‑over‑year, and operating margins are thin, while the overall profit margin is negative. The company carries a debt load that dwarfs its equity, creating a leverage profile that is markedly risky. Cash flow from operations is modest and free cash flow is positive but limited relative to debt obligations. The dividend yield sits in the high single digits, yet the payout ratio exceeds earnings, raising doubts about sustainability. Valuation metrics paint a mixed picture: a low forward price‑to‑earnings suggests cheapness, but a discounted cash flow model places intrinsic value far below the market price, implying overvaluation. Analyst coverage is sparse and recent downgrades temper optimism, while the stock’s upside potential appears constrained by the bearish technical backdrop.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • bearish SMA alignment
  • negative profit margin
  • high leverage

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • potential MACD reversal
  • low forward PE
  • dividend yield attractiveness if sustained

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • structural brand portfolio
  • possible improvement in core sales
  • ongoing debt reduction efforts

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
Profit Margin-3.91%
P/E Ratio6.6
ROE-11.17%
ROA2.73%
Debt/Equity243.13
P/B Ratio0.8
Op. Cash Flow$244.0M
Free Cash Flow$432.6M

Technical Analysis

TrendBearish
RSI63.5
Support$3.20
Resistance$4.49
MA 20$3.71
MA 50$3.92
MA 200$4.30
MACDBullish
VolumeIncreasing
Fear & Greed Index85.57

Valuation

Fair Value$0.36
Target Price$4.94
Upside/Downside12.86%
GradeOvervalued
TypeValue
Dividend Yield6.65%

Risk Assessment

Beta1.59
Volatility78.92%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.